-
公开(公告)号：AU2016331925B2
公开(公告)日：2021-04-22
申请号：AU2016331925
申请日：2016-09-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
Abstract: Devices can be implanted in an eye to treat a dry eye condition. The devices include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. In some embodiments, the device is filterless. In some embodiments, a filter is included. The dry eye treatment devices provided herein prevent bacterial ingress, provide outflow resistance to retain a normal intraocular pressure, and provide moisture (e.g., aqueous humor) to an otherwise dry eye. Methods of treating a dry eye condition wherein the device is implanted in the sclera of an afflicted eye are also described.
-
公开(公告)号：AU2016353229B2
公开(公告)日：2021-05-06
申请号：AU2016353229
申请日：2016-11-11
Applicant: MICROOPTX INC
Inventor： MARTIN ROY CHRISTIAN , PULLING CHRISTOPHER CLARK , MARTIN CHRISTOPHER THOMAS , BROWN J DAVID
IPC: A61B3/12 , A61B5/1455 , A61B5/1459
Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.
-
公开(公告)号：AU2015374033A1
公开(公告)日：2017-07-13
申请号：AU2015374033
申请日：2015-12-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
Abstract: Devices can be implanted in an eye to treat glaucoma. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. By the strategic selection of particular materials of construction, and/or by controlling the configuration and size of the lumen, in some embodiments, the device is a filterless construct. In some embodiments, a filter is included. The glaucoma treatment devices as provided herein are designed to prevent bacterial ingress and to provide the required level of outflow resistance to achieve a desired intraocular pressure. Methods of treating glaucoma wherein the device is implanted in the sclera of an afflicted eye are also described.
-
公开(公告)号：AU2017293767B2
公开(公告)日：2021-12-16
申请号：AU2017293767
申请日：2017-07-05
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID , PULLING CHRISTOPHER CLARK , MARTIN ROY CHRISTIAN , COHEN EDWARD AARON
Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.
-
公开(公告)号：CA2972195A1
公开(公告)日：2016-07-07
申请号：CA2972195
申请日：2015-12-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
IPC: A61B3/16
Abstract: Devices can be implanted in an eye to treat glaucoma. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. By the strategic selection of particular materials of construction, and/or by controlling the configuration and size of the lumen, in some embodiments, the device is a filterless construct. In some embodiments, a filter is included. The glaucoma treatment devices as provided herein are designed to prevent bacterial ingress and to provide the required level of outflow resistance to achieve a desired intraocular pressure. Methods of treating glaucoma wherein the device is implanted in the sclera of an afflicted eye are also described.
-
Patent Agency Ranking
公开(公告)号：CA3000402A1
公开(公告)日：2017-04-06
申请号：CA3000402
申请日：2016-09-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
Abstract: Devices can be implanted in an eye to treat a dry eye condition. The devices include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. In some embodiments, the device is filterless. In some embodiments, a filter is included. The dry eye treatment devices provided herein prevent bacterial ingress, provide outflow resistance to retain a normal intraocular pressure, and provide moisture (e.g., aqueous humor) to an otherwise dry eye. Methods of treating a dry eye condition wherein the device is implanted in the sclera of an afflicted eye are also described.
-
公开(公告)号：AU2015374033B2
公开(公告)日：2020-07-02
申请号：AU2015374033
申请日：2015-12-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
Abstract: Devices can be implanted in an eye to treat glaucoma. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. By the strategic selection of particular materials of construction, and/or by controlling the configuration and size of the lumen, in some embodiments, the device is a filterless construct. In some embodiments, a filter is included. The glaucoma treatment devices as provided herein are designed to prevent bacterial ingress and to provide the required level of outflow resistance to achieve a desired intraocular pressure. Methods of treating glaucoma wherein the device is implanted in the sclera of an afflicted eye are also described.
-
公开(公告)号：AU2017293767A1
公开(公告)日：2019-01-03
申请号：AU2017293767
申请日：2017-07-05
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID , PULLING CHRISTOPHER CLARK , MARTIN ROY CHRISTIAN , COHEN EDWARD AARON
Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.
-
公开(公告)号：AU2016353229A1
公开(公告)日：2018-05-31
申请号：AU2016353229
申请日：2016-11-11
Applicant: MICROOPTX INC
Inventor： MARTIN ROY CHRISTIAN , PULLING CHRISTOPHER CLARK , MARTIN CHRISTOPHER THOMAS , BROWN J DAVID
IPC: A61B3/12 , A61B5/1455 , A61B5/1459
Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.
-
公开(公告)号：AU2016331925A1
公开(公告)日：2018-04-26
申请号：AU2016331925
申请日：2016-09-30
Applicant: MICROOPTX INC
Inventor： BROWN J DAVID
Abstract: Devices can be implanted in an eye to treat a dry eye condition. The devices include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. In some embodiments, the device is filterless. In some embodiments, a filter is included. The dry eye treatment devices provided herein prevent bacterial ingress, provide outflow resistance to retain a normal intraocular pressure, and provide moisture (e.g., aqueous humor) to an otherwise dry eye. Methods of treating a dry eye condition wherein the device is implanted in the sclera of an afflicted eye are also described.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.026 seconds)
